Results 231 to 240 of about 2,570,930 (351)
Tuberculosis in Renal Transplant Recipients
S. Ersan +8 more
semanticscholar +1 more source
Objective High‐intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced systemic sclerosis (SSc). The role of reduced‐intensity conditioning (RIC) before AHSCT in this population remains unclear.
Yonatan Lean +4 more
wiley +1 more source
Febuxostat effectively reduces uric acid but has a limited renoprotective effect on renal transplant recipients with hyperuricemia: a meta-analysis. [PDF]
Chao S, Zhu K, Jia L, Liu Y.
europepmc +1 more source
Objective The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasingly available immunosuppressive therapies (ISTs) and antifibrotic treatments. However, their real‐world use remains unclear.
Corrado Campochiaro +17 more
wiley +1 more source
Characterization of Beta-Lactam Allergy and Outcomes Associated With Perioperative Antibiotic Choice in Renal Transplant Recipients. [PDF]
Nolan A +3 more
europepmc +1 more source
Objectives Still's Disease represents a prototypical polygenic systemic autoinflammatory diseases (SAIDs), characterized by recurrent systemic inflammation and dysregulation of innate immunity. Despite extensive clinical characterization, familial clustering Still's disease remains unreported.
Longfang Chen +23 more
wiley +1 more source
Association between delayed graft function and cytomegalovirus infection after renal transplant. [PDF]
Liu L +8 more
europepmc +1 more source
Inflammation-associated graft loss in renal transplant recipients.
D. O. Dahle +12 more
semanticscholar +1 more source

